Ingrid Henneke

Giessen, HE, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Microscopic computed tomography with AI-CNN-powered image analysis: the path to phenotype bleomycin-induced lung injury.

Microscopic computed tomography with AI-CNN-powered image analysis: the path to phenotype bleomycin-induced lung injury.

Journal: American journal of physiology. Cell physiology

Published: April 22, 2024

Erratum: Antihistone Properties of C1 Esterase Inhibitor Protect against Lung Injury.

Erratum: Antihistone Properties of C1 Esterase Inhibitor Protect against Lung Injury.

Journal: American journal of respiratory and critical care medicine

Published: November 01, 2022

Notch1 Induces Defective Epithelial Surfactant Processing and Pulmonary Fibrosis.

Notch1 Induces Defective Epithelial Surfactant Processing and Pulmonary Fibrosis.

Journal: American journal of respiratory and critical care medicine

Published: September 01, 2022

PINK1-mediated Mitophagy Contributes to Pulmonary Vascular Remodeling in Pulmonary Hypertension.

PINK1-mediated Mitophagy Contributes to Pulmonary Vascular Remodeling in Pulmonary Hypertension.

Journal: American journal of respiratory cell and molecular biology

Published: July 30, 2021

Author Correction: NADPH oxidase subunit NOXO1 is a target for emphysema treatment in COPD.

Author Correction: NADPH oxidase subunit NOXO1 is a target for emphysema treatment in COPD.

Journal: Nature metabolism

Published: July 23, 2020

NADPH oxidase subunit NOXO1 is a target for emphysema treatment in COPD.

NADPH oxidase subunit NOXO1 is a target for emphysema treatment in COPD.

Journal: Nature metabolism

Published: February 25, 2020

Evidence for the Fucoidan/P-Selectin Axis as a Therapeutic Target in Hypoxia-induced Pulmonary Hypertension.

Evidence for the Fucoidan/P-Selectin Axis as a Therapeutic Target in Hypoxia-induced Pulmonary Hypertension.

Journal: American journal of respiratory and critical care medicine

Published: December 18, 2018

Regulation and role of the ER stress transcription factor CHOP in alveolar epithelial type-II cells.

Regulation and role of the ER stress transcription factor CHOP in alveolar epithelial type-II cells.

Journal: Journal of molecular medicine (Berlin, Germany)

Published: August 08, 2018

Two-Way Conversion between Lipogenic and Myogenic Fibroblastic Phenotypes Marks the Progression and Resolution of Lung Fibrosis.

Two-Way Conversion between Lipogenic and Myogenic Fibroblastic Phenotypes Marks the Progression and Resolution of Lung Fibrosis.

Journal: Cell stem cell

Published: April 08, 2017

Antihistone Properties of C1 Esterase Inhibitor Protect against Lung Injury.

Antihistone Properties of C1 Esterase Inhibitor Protect against Lung Injury.

Journal: American journal of respiratory and critical care medicine

Published: December 23, 2016

Two-Way Conversion between Lipogenic and Myogenic Fibroblastic Phenotypes Marks the Progression and Resolution of Lung Fibrosis.

Two-Way Conversion between Lipogenic and Myogenic Fibroblastic Phenotypes Marks the Progression and Resolution of Lung Fibrosis.

Journal: Cell stem cell

Published: October 26, 2015

MAP1LC3B overexpression protects against Hermansky-Pudlak syndrome type-1-induced defective autophagy in vitro.

MAP1LC3B overexpression protects against Hermansky-Pudlak syndrome type-1-induced defective autophagy in vitro.

Journal: American journal of physiology. Lung cellular and molecular physiology

Published: June 30, 2015

Showing 1-12 of 20

Last Updated: 09/26/2026